Fate Therapeutics

In News

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

GlobeNewswire - Mar 04, 2026

FATE: FT819 shows promising efficacy and safety in lupus nephritis, with pivotal trials set for later this year - TradingView

TradingView - Mar 09, 2026

Fate Therapeutics at Leerink Global Healthcare Conference: Strategic Shift in Focus - Investing.com UK

Investing.com UK - Mar 09, 2026

Companies Like Fate Therapeutics (NASDAQ:FATE) Could Be Quite Risky - Yahoo Finance

Yahoo Finance - Dec 21, 2025

Fate Therapeutics (FATE) Reports Q4 Loss, Misses Revenue Estimates - Nasdaq

Nasdaq - Feb 26, 2026

Great week for Fate Therapeutics, Inc. (NASDAQ:FATE) institutional investors after losing 6.3% over the previous year - simplywall.st

simplywall.st - Jan 17, 2026

Fate Therapeutics (NASDAQ: FATE) cuts 2025 expenses, extends cash runway - Stock Titan

Stock Titan - Feb 26, 2026

Biotech layoffs: Fate, Generation Bio, ORIC trim teams and pipelines - FirstWord Pharma

FirstWord Pharma - Aug 13, 2025

Fate Therapeutics Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo

Markets Mojo - Mar 08, 2026

Fate Therapeutics to Participate in Leerink Partners 2026 Global Healthcare Conference - GlobeNewswire

GlobeNewswire - Mar 03, 2026

Fate Therapeutics earnings beat, revenue topped estimates - Investing.com

Investing.com - Feb 26, 2026

Fate Therapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview - TradingView

TradingView - Feb 27, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment